Literature DB >> 22224068

Adrenal ganglioneuroma with multifocal retroperitoneal extension: a challenging diagnosis.

Marco Oderda1, Elena Cattaneo, Francesco Soria, Antonella Barreca, Luigi Chiusa, Bruno Morelli, Andrea Zitella, Paolo Gontero.   

Abstract

A ganglioneuroma (GN) is the rarest and most benign of the neuroblastic tumors and originates from neural crest cells wherever sympathetic nervous tissue exists, such as in the retroperitoneum and adrenal gland. The diagnosis can be very challenging, given the rarity and asymptomatic presentation of this neoplasia, and can be achieved only by means of histological evaluation. Although benign, a few cases of metastatic GNs have been reported in the literature. The prognosis, however, seems to be excellent after surgical resection. We describe a rare case of multifocal retroperitoneal GN, diagnosed incidentally in a 46-year-old woman, with para-aortic and adrenal localizations. After intraoperative pathological diagnosis was made, complete excision of all the visible masses was performed. The postoperative period was uneventful and she was recurrence free 3 months after surgery. To our knowledge, this is the first case report of a multifocal retroperitoneal GN. Among the broad differential diagnoses of adrenal incidentalomas, an adrenal location of neuroblastic tumors should not be forgotten.

Entities:  

Mesh:

Year:  2011        PMID: 22224068      PMCID: PMC3201631          DOI: 10.1100/tsw.2011.144

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  2 in total

1.  Organ Preservation in a Case of Retroperitoneal Ganglioneuroma: A Case Report and Review of Literature.

Authors:  Santosh Kumar; Shivanshu Singh; Abhishek Chandna
Journal:  Case Rep Surg       Date:  2016-09-07

2.  A Large Retroperitoneal Ganglioneuroma Presenting With an Abdominal Pain: A Case Report.

Authors:  Sultanah Bin Gheshayan; Danah Alsadun; Alanood Alharbi; Nahar A Alselaim
Journal:  Cureus       Date:  2021-12-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.